Word: sandoz
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...psychoanalysis, Vasella says, helped free him "from the rules and obligations one imposes on oneself" and give him the courage to leap into a new career. In 1987 he sought the advice of Max Link, the well-connected and accessible head of the drug business for Swiss conglomerate Sandoz. Vasella was offered a job and sent to learn the ropes at the company's headquarters in East Hanover...
...trainee--but one with a rocket strapped to his back. A year after joining Sandoz, Vasella became product manager for a new drug named Sandostatin, approved to treat a rare pancreatic cancer. The head of Sandoz's U.S. pharmaceutical unit joked that Vasella could consider his job well done if he made Sandostatin a $5 million product, a pittance in the branded-drug business. Vasella realized that to make Sandostatin a commercial success, he had to find new uses for it. And he believed he could do that only by radically changing the game...
...Sandoz, as at most pharmaceutical companies in those days, new products came to market through a linear, three-step sequence. Researchers would seek out potential drugs. Development teams would test and refine them in hopes of winning regulatory approval. Finally, marketers would peddle the approved drugs to physicians. These steps were typically conducted in isolation, so developers would sometimes find out too late that a candidate drug had terrible side effects or could not be mass-produced economically. Or marketers would discover late in the process that there wasn't much demand for the new drug they would soon...
...long. In 1993 Vasella returned to Switzerland to head corporate marketing at Sandoz headquarters in Basel. The next year he briefly led the company's global drug-development programs, and he was its chief operating officer before becoming CEO of its drug business, reporting to the chairman of the conglomerate, Marc Moret--his wife's uncle. Vasella applied the lessons he had learned while managing Sandostatin to all the company's drug-development efforts. When Sandoz announced in 1996 that it would merge with its rival across the Rhine, Ciba-Geigy, Vasella was named CEO of the new company...
...1960s, the pharmaceutical company Sandoz marketed its new tranquilizer Serentil with ads in medical journals suggesting the drug be prescribed to "the newcomer in town who can't make friends ... The woman who can't get along with her new daughter-in-law. The executive who can't accept retirement." But the FDA stopped the ads. Drugs are supposed to treat illnesses, the agency said, not the vicissitudes of living...